These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Biological activity of CD-ring modified 1alpha,25-dihydroxyvitamin D analogues: C-ring and five-membered D-ring analogues. Verstuyf A; Verlinden L; van Etten E; Shi L; Wu Y; D'Halleweyn C; Van Haver D; Zhu GD; Chen YJ; Zhou X; Haussler MR; De Clercq P; Vandewalle M; Van Baelen H; Mathieu C; Bouillon R J Bone Miner Res; 2000 Feb; 15(2):237-52. PubMed ID: 10703925 [TBL] [Abstract][Full Text] [Related]
24. An expedited approach to the vitamin D trans-hydrindane building block from the Hajos dione. Chochrek P; Wicha J Org Lett; 2006 Jun; 8(12):2551-3. PubMed ID: 16737311 [TBL] [Abstract][Full Text] [Related]
25. New derivatives of 1alpha,25-dihydroxy-19-norvitamin D3 with two substituents at C-2: synthesis and biological activity. Shimizu M; Iwasaki Y; Shimazaki M; Amano Y; Yamamoto K; Reischl W; Yamada S Bioorg Med Chem Lett; 2005 Mar; 15(5):1451-5. PubMed ID: 15713405 [TBL] [Abstract][Full Text] [Related]
26. Practical synthesis and evaluation of the biological activities of 1alpha,25-dihydroxyvitamin D3 antagonists, 1alpha,25-dihydroxyvitamin D3-26,23-lactams. Designed on the basis of the helix 12-folding inhibition hypothesis. Nakano Y; Kato Y; Imai K; Ochiai E; Namekawa J; Ishizuka S; Takenouchi K; Tanatani A; Hashimoto Y; Nagasawa K J Med Chem; 2006 Apr; 49(8):2398-406. PubMed ID: 16610783 [TBL] [Abstract][Full Text] [Related]
27. Catalytic asymmetric syntheses and biological activities of singly dehydroxylated 19-nor-1alpha,25-dihydroxyvitamin D(3) A-ring analogs in cancer cell differentiation and apoptosis. Okano T; Nakagawa K; Kubodera N; Ozono K; Isaka A; Osawa A; Terada M; Mikami K Chem Biol; 2000 Mar; 7(3):173-84. PubMed ID: 10712934 [TBL] [Abstract][Full Text] [Related]
28. The first locked side-chain analogues of calcitriol (1alpha,25-dihydroxyvitamin D3) induce vitamin D receptor transcriptional activity. Pérez-García X; Rumbo A; Larriba MJ; Ordóñez P; Muñoz A; Mouriño A Org Lett; 2003 Oct; 5(22):4033-6. PubMed ID: 14572242 [TBL] [Abstract][Full Text] [Related]
29. An efficient convergent synthesis of 1α,25-dihydroxy-3-epi-vitamin D2. Sigüeiro R; Otero R; González-Berdullas P; Maestro M; Mouriño A J Steroid Biochem Mol Biol; 2015 Apr; 148():31-3. PubMed ID: 25460301 [TBL] [Abstract][Full Text] [Related]
30. New 2-alkylidene 1alpha,25-dihydroxy-19-norvitamin D3 analogues of high intestinal activity: synthesis and biological evaluation of 2-(3'-alkoxypropylidene) and 2-(3'-hydroxypropylidene) derivatives. Glebocka A; Sicinski RR; Plum LA; Clagett-Dame M; DeLuca HF J Med Chem; 2006 May; 49(10):2909-20. PubMed ID: 16686534 [TBL] [Abstract][Full Text] [Related]
31. Efficient and practical synthesis of the A-ring precursor of 19-nor-1alpha,25-dihydroxyvitamin D(3) and its (13)C- or (2)H-labeled derivative. Hanazawa T; Inamori H; Masuda T; Okamoto S; Sato F Org Lett; 2001 Jul; 3(14):2205-7. PubMed ID: 11440580 [TBL] [Abstract][Full Text] [Related]
32. Synthesis of putative metabolites of 1alpha,25-dihydroxy-2beta-(3-hydroxypropoxy)vitamin D(3) (ED-71). Ono Y; Watanabe H; Taira I; Takahashi K; Ishihara J; Hatakeyama S; Kubodera N Steroids; 2006 Jul; 71(7):529-40. PubMed ID: 16635499 [TBL] [Abstract][Full Text] [Related]
33. Conceptually new sulfone analogues of the hormone 1alpha, 25-dihydroxyvitamin D(3): synthesis and preliminary biological evaluation. Posner GH; Wang Q; Han G; Lee JK; Crawford K; Zand S; Brem H; Peleg S; Dolan P; Kensler TW J Med Chem; 1999 Sep; 42(18):3425-35. PubMed ID: 10479276 [TBL] [Abstract][Full Text] [Related]
34. Low-calcemic, highly antiproliferative, 1-difluoromethyl hybrid analogs of the natural hormone 1alpha,25-dihydroxyvitamin D3: design, synthesis, and preliminary biological evaluation. Peleg S; Petersen KS; Suh BC; Dolan P; Agoston ES; Kensler TW; Posner GH J Med Chem; 2006 Dec; 49(25):7513-7. PubMed ID: 17149880 [TBL] [Abstract][Full Text] [Related]
35. 2,2-Functionalized analogues of 1alpha,25-dihydroxyvitamin D3, the potent inducers of cell differentiation. Fujishima T; Kittaka A; Kurihara M; Saito N; Honzawa S; Kishimoto S; Sugiura T; Waku K; Takayama H J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):89-92. PubMed ID: 15225752 [TBL] [Abstract][Full Text] [Related]
36. New derivative of 1alpha,25-dihydroxy-19-norvitamin D3 with 3'-alkoxypropylidene moiety at C-2: synthesis, biological activity and conformational analysis. Glebocka A; Sicinski RR; DeLuca HF J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):25-30. PubMed ID: 15225741 [TBL] [Abstract][Full Text] [Related]
38. The development of CD-ring modified analogs of 1alpha,25-dihydroxyvitamin D. De Clercq PJ; De Buysser F; Minne G; Schepens W; Vrielynck F; Van Haver D; Vandewalle M; Verstuyf A; Bouillon R J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):206-12. PubMed ID: 17218098 [TBL] [Abstract][Full Text] [Related]
39. Novel synthetic approach to 19-nor-1alpha,25-dihydroxyvitamin D(3) and its derivatives by Suzuki-Miyaura coupling in solution and on solid support. Hanazawa T; Wada T; Masuda T; Okamoto S; Sato F Org Lett; 2001 Nov; 3(24):3975-7. PubMed ID: 11720583 [TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationship studies on vitamin D lactam derivatives as vitamin D receptor antagonist. Cho K; Uneuchi F; Kato-Nakamura Y; Namekawa J; Ishizuka S; Takenouchi K; Nagasawa K Bioorg Med Chem Lett; 2008 Aug; 18(15):4287-90. PubMed ID: 18635349 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]